Physician profile
William B Devoe
NPI 1770849507
$35,530.76
in general payments reported to CMS, 2019-2025
46 companies · $632 in 2025
The $632 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $233 · 2021: $10K · 2022: $6,723 · 2023: $7,494 · 2024: $9,998 · 2025: $632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,825 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,750 · Food and Beverage: $2,342 · Travel and Lodging: $2,034 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,825.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,750.00 |
| Food and Beverage | $2,341.93 |
| Travel and Lodging | $2,033.51 |
| Education | $173.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $29,563.04 | 2019-2024 | Ribloc, Acutie II, Biobridge |
| Intuitive Surgical, INC. | $2,679.26 | 2022-2025 | Da Vinci Surgical System |
| Takeda Pharmaceuticals U.S.A., INC. | $446.33 | 2020-2025 | Gattex |
| Smith+Nephew, INC. | $396.34 | 2019-2025 | Collagenase Santyl, Pico 14, Renasys Touch |
| Ethicon US, LLC | $314.61 | 2019-2025 | Echelon; Endopath, Echelon Endopath, Stratafix |
| Davol INC. | $280.12 | 2019-2025 | Phasix Mesh |
| Csl Behring | $208.14 | 2019-2025 | Kcentra |
| Medtronic, INC. | $164.28 | 2021-2023 | Ligasure |
| Depuy Synthes Sales INC. | $125.26 | 2021-2025 | Matrixrib |
| Abbvie INC. | $106.32 | 2023-2024 | Strattice Reconstructive Tissue Matrix Bps |
| Conmed Corporation | $95.10 | 2022-2025 | Airseal, Conmed Specimen Retrieval |
| Merck Sharp & Dohme LLC | $92.34 | 2020-2021 | |
| Atricure, INC. | $86.54 | 2022-2023 | |
| Vertex Pharmaceuticals Incorporated | $82.94 | 2025 | |
| Sanara Medtech INC. | $77.49 | 2020-2025 | Celleraterx |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Devoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.